RhoC-GTPase is a novel tissue biomarker associated with biologically aggressive carcinomas of the breast

Breast Cancer Research and Treatment

Volumn 93, Issue 2, 2005, Pages 101-110

  Kleer, Celina G ^a,b,c   Griffith, Kent A ^a,b   Sabel, Michael S ^a,b   Gallagher, Gary ^a   Van Golen, Kenneth L ^a,b   Wu, Zhi Fen ^a,b   Merajver, Sofia D ^a,b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN COMPREHENSIVE CANCER CENTER   (United States)

^c UNIVERSITY OF MICHIGAN HOSPITALS   (United States)

Author keywords

Biomarkers; Breast cancer; Inflammatory breast cancer; Pathology; Rhoc; Tissue microarrays

Indexed keywords

BIOLOGICAL MARKER; CYCLOPHOSPHAMIDE; DOXORUBICIN; HORMONE RECEPTOR; PACLITAXEL; POLYCLONAL ANTIBODY; POLYCLONAL RHOC ANTIBODY; PROTEIN RHOC; RHO FACTOR; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BREAST CARCINOMA; BREAST DISEASE; BREAST DUCT; BREAST HYPERPLASIA; CANCER GROWTH; CANCER PATIENT; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CARCINOMA IN SITU; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOPLASM; DISEASE ASSOCIATION; DISEASE COURSE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPOTHESIS; IMMUNOHISTOCHEMISTRY; INFLAMMATORY DISEASE; INVASIVE CARCINOMA; KRUSKAL WALLIS TEST; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; METASTASIS; OUTCOMES RESEARCH; PREDICTION; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; RISK ASSESSMENT; SAMPLE; SCORING SYSTEM; TISSUE MICROARRAY;

BREAST NEOPLASMS; DISEASE PROGRESSION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; PROGNOSIS; REPRODUCIBILITY OF RESULTS; RHO GTP-BINDING PROTEINS; SURVIVAL RATE; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 25844484093     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10549-005-4170-6     Document Type: Article

References (40)

1. A Jemal T Murray A Samuels A Ghafoor E Ward MJ Thun 2003 Cancer statistics CA Cancer J Clin 53 5 26
2. M Ellis D Hayes M Lippman 2000 Treatment of metastatic disease J Harris ME Lippman M Morrow Diseases of the Breast Lippincott-Raven Philadelpha 749 798
3. DF Hayes C Isaacs V Stearns 2001 Prognostic factors in breast cancer: current and new predictors of metastasis J Mammary Gland Biol Neoplasia 6 375 392
4. DF Hayes B Trock AL Harris 1998 Assessing the clinical impact of prognostic factors: when is "statistically significant" clinically useful? Breast Cancer Res Treat 52 305 319
5. GM Clark 1996 Prognostic and predictive factors LM. J Harris M Morrow S Hellman, Diseases of the Breast Lipponcott-Raven Publishers Philadephia 461 485
6. Hayes 2000 Do we need prognostic factors in nodal-negative breast cancer? Arbiter Eur J Cancer 36 302 306
7. KL van Golen S Davies ZF Wu Y Wang CD Bucana H Root S Chandrasekharappa M Strawderman SP Ethier SD Merajver 1999 A novel putative low-affinity insulin-like growth factor-binding protein, LIBC (lost in inflammatory breast cancer), and RhoC GTPase correlate with the inflammatory breast cancer phenotype Clin Cancer Res 5 2511 2519
8. KL van Golen ZF Wu XT Qiao L Bao SD Merajver 2000 RhoC GTPase overexpression modulates induction of angiogenic factors in breast cells Neoplasia 2 418 425
9. KL van Golen ZF Wu XT Qiao LW Bao SD Merajver 2000 RhoC GTPase, a novel transforming oncogene for human mammary epithelial cells that partially recapitulates the inflammatory breast cancer phenotype Cancer Res 60 5832 5838
10. CG Kleer KL van Golen Y Zhang ZF Wu MA Rubin SD Merajver 2002 Characterization of RhoC expression in benign and malignant breast disease:a potential new marker for small breast carcinomas with metastatic ability Am J Pathol 160 579 584
11. CG Kleer Q Cao S Varambally R Shen I Ota SA Tomlins D Ghosh RG Sewalt AP Otte DF Hayes MS Sabel D Livant SJ Weiss MA Rubin AM Chinnaiyan 2003 EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells Proc Natl Acad Sci USA 100 11606 11611
12. EE Perrone C Theoharis NR Mucci S Hayasaka JM Taylor KA Cooney MA Rubin 2000 Tissue microarray assessment of prostate cancer tumor proliferation in African-American and white men J Natl Cancer Inst 92 937 939
13. EW Elston IO Ellis 1993 Method for grading breast cancer J Clin Pathol 46 189 190
14. S Manley NR Mucci AM De Marzo MA Rubin 2001 Relational database structure to manage high-density tissue microarray data and images for pathology studies focusing on clinical outcome: the prostate specialized program of research excellence model Am J Pathol 159 837 843
15. DR Rhodes MG Sanda AP Otte AM Chinnaiyan MA Rubin 2003 Multiplex biomarker approach for determining risk of prostate-specific antigen-defined recurrence of prostate cancer J Natl Cancer Inst 95 661 668
16. CD Nobes A Hall 1995 Rho, rac, and cdc42 GTPases regulate the assembly of multimolecular focal complexes associated with actin stress fibers, lamellipodia, and filopodia Cell 81 53 62
17. A Hall CD Nobes 2000 Rho GT Pases molecular switches that control the organization and dynamics of the actin cytoskeleton Philos Trans R Soc Lond B Biol Sci 355 965 970
18. T Leung XQ Chen E Manser L Lim 1996 The p160 RhoA-binding kinase ROK alpha is a member of a kinase family and is involved in the reorganization of the cytoskeleton Mol Cell Biol 16 5313 5327
19. CG Kleer Y Zhang Q Pan G Gallagher M Wu ZF Wu SD Merajver 2004 WISP3 and RhoC guanosine triphosphatase cooperate in the development of inflammatory breast cancer Breast Cancer Res 6 R110 R115
20. MA Wozniak R Desai PA Solski CJ Der PJ Keely 2003 ROCK-generated contractility regulates breast epithelial cell differentiation in response to the physical properties of a three-dimensional collagen matrix J Cell Biol 163 583 595
21. H Suwa G Ohshio T Imamura G Watanabe S Arii M Imamura S Narumiya H Hiai M Fukumoto 1998 Overexpression of the RhoC gene correlates with progression of ductal adenocarcinoma of the pancreas Br J Cancer 77 147 152
22. A Horiuchi T Imai C Wang S Ohira Y Feng T Nikaido I Konishi 2003 Up-regulation of small GTPases, RhoA and RhoC, is associated with tumor progression in ovarian carcinoma Lab Invest 83 861 870
23. T Kamai T Tsujii K Arai K Takagi H Asami Y Ito H Oshima 2003 Significant association of Rho/ROCK pathway with invasion and metastasis of bladder cancer Clin Cancer Res 9 2632 2641
24. T Kondo K Sentani N Oue K Yoshida H Nakayama W Yasui 2004 Expression of RHOC is associated with metastasis of gastric carcinomas Pathobiology 71 19 25
25. Y Shikada I Yoshino T Okamoto S Fukuyama T Kameyama Y Maehara 2003 Higher expression of RhoC is related to invasiveness in non-small cell lung carcinoma Clin Cancer Res 9 5282 5286
26. W Wang LY Yang ZL Yang GW Huang WQ Lu 2003 Expression and significance of RhoC gene in hepatocellular carcinoma World J Gastroenterol 9 1950 1953
27. T Ikoma T Takahashi S Nagano YM Li Y Ohno K Ando T Fujiwara H Fujiwara K Kosai 2004 A definitive role of RhoC in metastasis of orthotopic lung cancer in mice Clin Cancer Res 10 1192 1200
28. EA Clark TR Golub ES Lander RO Hynes 2000 Genomic analysis of metastasis reveals an essential role for RhoC Nature 406 532 535
29. KM Carr M Bittner JM Trent 2003 Gene-expression profiling in human cutaneous melanoma Oncogene 22 3076 3080
30. MC Seabra 1998 Membrane association and targeting of prenylated Ras-like GTPases Cell Signal 10 167 172
31. PT Kirschmeier D Whyte O Wilson WR Bishop JK Pai 2001 In vivo prenylation analysis of Ras and Rho proteins Methods Enzymol 332 115 127
32. P Adamson CJ Marshall A Hall PA Tilbrook 1992 Post-translational modifications of p21rho proteins J Biol Chem 267 20033 20038
33. M Sinensky 2000 Recent advances in the study of prenylated proteins Biochim Biophys Acta 1484 93 106
34. AL Bishop A Hall 2000 Rho GTPases and their effector proteins Biochem J 348 Pt2 241 255
35. CA Omer Z Chen RE Diehl MW Conner HY Chen ME Trumbauer S Gopal-Truter G Seeburger H Bhimnathwala MT Abrams JP Davide MS Ellis JB Gibbs I Greenberg KS Koblan AM Kral D Liu RB Lobell PJ Miller SD Mosser TJ O'Neill E Rands MD Schaber ET Senderak A Oliff NE Kohl 2000 Mouse mammary tumor virus-Ki-rasB transgenic mice develop mammary carcinomas that can be growth-inhibited by a farnesyl:protein transferase inhibitor Cancer Res 60 2680 2688
36. GC Prendergast R Khosravi-Far PA Solski H Kurzawa PF Lebowitz Der CJ 1995 Critical role of Rho in cell transformation by oncogenic Ras Oncogene 10 2289 2296
37. GC Prendergast JP Davide SJ deSolms EA Giuliani SL Graham JB Gibbs A Oliff NE Kohl 1994 Farnesyltransferase inhibition causes morphological reversion of ras-transformed cells by a complex mechanism that involves regulation of the actin cytoskeleton Mol Cell Biol 14 4193 4202
38. PF Lebowitz PJ Casey GC Prendergast JA Thissen 1997 Farnesyltransferase inhibitors alter the prenylation and growth-stimulating function of RhoB J Biol Chem 272 15591 15594
39. KL van Golen L Bao MM DiVito Z Wu GC Prendergast SD Merajver 2002 Reversion of RhoC GTPase-induced inflammatory breast cancer phenotype by treatment with a farnesyl transferase inhibitor Mol Cancer Ther 1 575 583
40. EA Collisson C Kleer M Wu A De SS Gambhir SD Merajver MS Kolodney 2003 Atorvastatin prevents RhoC isoprenylation, invasion, and metastasis in human melanoma cells Mol Cancer Ther 2 941 948